Måndag 6 februari
| 10:00-10:15 | Welcome to Sweden Liver Week 2023
Andreas Schult |
| 10:15-10:30 | Introduction to the dynamics of advanced chronic liver failure
Anna Cederborg |
| 10:30-11:00 | Hepatology consultation #1 First decompensation in cirrhosis- What is important to do right now
Ingalill Friis-LibyHelgi Björnsson |
| 11:00-11:45 | Hepatology consultation #2 Late decompensation- What can be done still?
Ingalill Friis-LibyHanna ChinHelgi Björnsson |
| 11:45-12:30 | Decompensation in children with chronic liver disease
Girish Gupte |
| 13:30-14:00 | Pitfalls for radiological assessment of HCC
Mats Andersson |
| 14:00-14:30 | Systemic treatment of HCC – what every HPB surgeon should know
Per Stål |
| 14:30-15:00 | ASA as prophylaxis for HCC
Jonas Ludvigsson |
| 15:00-15:30 | Coffee break |
| 15:30-16:30 | Debate: Feasibilities of and prerequisites for curative treatment in HCC
Jacob FreedmanOskar Hemmingsson |
| 13:30-13:35 | Välkomna och praktisk information
Karin EdlundMalin Aram |
| 13:35-14:05 | Varför transplanteras barn? Indikationer, diagnoser, resultat.
Ulrika HärenstamNils Ekvall |
| 14:05-14:35 | ”Jag lever” – en självbiografisk skildring om att vara ung och levertransplanterad, tre gånger
Agnes HultbergMoa Flink |
| 14:35-15:00 | Coffee break |
| 15:00-15:30 | Utredning, operation och uppföljning av en levande leverdonator
William Bennet |
| 15:30-16:15 | Att vara förälder till ett leversjukt barn och plötsligt själv bli patient (levande leverdonator)
Ulrika Pizzeghello Johansson |
| 16:15-16:30 | Summering & Utvärdering |
| 16:45-17:45 | Cholestatic Liver Disease – From treating cholestasis and pruritus to improving native liver survival
Patrick McKiernanHanns-Ulrich Marschall |
Tisdag 7 februari
| 08:30-09:00 | News in PSC: Implications of new guidelines and national highly specialized care (NHV)
Annika Bergquist |
| 09:00-09:40 | Diagnosis and treatment of severe alcoholic hepatitis without histological verification. What are the risks?
William Bernal |
| 09:40-10:00 | Hepatology consultation #3: Screening for bacterial infections in decompensated cirrhosis (recommendations from Baveno VII)
Antti Oksanen |
| 10:00-10:30 | Coffee break |
| 10:30-11:10 | State of the Art: Plasmaferesis in acute liver failure, immunological and neurological effects.
Fin Stolze Larsen |
| 11:10-11:50 | Hepatology consultation #4: ICU care in ACLF -implication of national highly specialized care (NHV)
Johan WaernJacob HolmqvistMiriam Burthun |
| 11:50-12:30 | Hepatology consultation #5: Portosinusoidal vascular disorder (PSVD)
Aurelier Plessier |
| 08:30-08:35 | Välkomna
Karin EdlundPia Loqvist |
| 08:35-09:45 | PREM och PROM: från mening till mätning – hur man mäter patientperspektiv
Anna Forsberg |
| 09:45-10:15 | Coffee break |
| 10:15-11:00 | Leverns funktion och dess utredningar
Andreas Schult |
| 11:00-11:40 | Omvårdnad enligt Nationella vårdprogrammet för levercirros
Maria Hjorth |
| 11:45-12:15 | Mat vid levercirros – vad ger vi för rekommendationer till våra
Catarina Lindkvist |
| 12:15-12:30 | Frågor, summering, utvärdering. Välkommen till Stockholm 2024
Karin EdlundMalin AramPia Loqvist |
| 08:30-08:35 | Welcome |
| 08:35-09:30 | Pruritus treatment in general and news about IBAT-inhibitors
Henrik Arnell |
| 09:30-10:00 | Immune dysregulation after liver transplantation
Timo Käppi |
| 10:00-10:30 | Coffee break |
| 10:30-11:15 | Drug Induced Liver Injury (DILI)
Girish Gupte |
| 11:15-11:45 | UK-hepatitis
Girish Gupte |
| 11:45-12:30 | Case-discussion |
| 13:30-15:00 | Acute and acute-on-chronic liver failure
Chair(s): Andreas SchultAntti Oksanen |
| 13:30-14:15 | State of the Art: Liver Transplantation for Acute Liver Failure
William Bernal |
| 14:15-14:45 | Liver Transplantation for ACLF grade 3 – Feasibility and Futility
Maria Antonella Burza |
| 14:45-15:00 | Results for National Prioritization for LT in ACLF grade 3
Andreas Schult |
| 15:00-15:30 | Coffee break |
| 15:30-17:00 | Liver transplantation – Expanding the donor pool
Chair(s): Ming YaoWilliam Bennet |
| 15:30-15:55 | ABO-incompatible liver transplantation for selected non-emergency cases?
Ulrika Skogsberg |
| 15:55-16:35 | Liver Grafts from DCD donors – An opportunity for everyone?
Gabriel Oniscu |
| 16:35-17:00 | Implementation of DCD for liver transplantation in Sweden
Carl Jorns |
| 13:30-14:15 | High content imaging in patient-derived models
Brinton Seashore-Ludlow |
| 14:15-15:00 | Liver-on-chips for improved drug screening and disease-on-chip
Caroline Adiels |
| 15:00-15:30 | Coffee break |
| 15:30-15:50 | Fire Talk: The mitochondrial amidoxime-reducing component 1 pAla165Thr reduces protein stability
Ester Ciociola |
| 15:50-16:10 | Fire Talk: Interleukin 32 downregulation lowers hepatocyte lipid content by reducing de novo triglyceride synthesis
Kavitha Sasidharan |
| 16:10-16:30 | Fire Talk: Unsupervised machine learning of MRI radiomics features for liver function stratification
Qiang Wang |
| 16:30-17:15 | Transcriptional guardian of lipid metabolism in liver diseases
Claudia Kutter |
Onsdag 8 februari
| 08:45-09:30 | Hepatic IKKẞ deletion improves fatty liver and insulin sensitivity
Vagner Ramon Silva |
| 09:30-09:50 | Fire Talk: Hepatocyte-specific depletion of the corepressor GPS2 alleviates atherosclerosis and dyslipidemia in mice
Sviatlana Sukhanava |
| 09:50-10:10 | Fire Talk: Does CD36 link hepatocyte cell proliferation and lipid metabolism?
Katharina Kuentzel |
| 10:10-10:30 | Fire Talk: Isotope tracing and metabolic flux analysis in human liver tissue ex vivo
Roland Nilsson |
| 10:30-11:00 | Coffee break |
| 11:00-11:45 | Micro- and nanostructures for biopsies, therapy and in-vitro modelling of pancreas and liver
Wouter van den Wijngaart |
| 11:45-12:30 | The employment of systems biology in treatment of NAFLD
Cheng Zhang |
| 09:00-09:30 | Screening in hepatology: Should we screen risk groups for advanced liver disease? (Pro/Con)
Per StålStergios Kechagias |
| 09:30-09:50 | Novel image-based biomarkers for non-invasive liver characterization
Hanna Hebelka |
| 09:50-10:20 | Hepatology consultation #6: Management of hemestasis and portal vein thrombosis in cirrhosis
Maria Magnusson |
| 10:20-10:50 | Coffee break |
| 10:50-11:30 | Use of albumin in advanced liver disease today and tomorrow
Anna CederborgAntti Oksanen |
| 11:30-12:15 | Summary of 2022 in Swedish hepatology och transplantation: Lessons from past and future directions
William BennetAnnika Bergquist |
| 12:15-12:30 | Concluding remarks
Per Stål |
